(Q42981662)

12 November 2017

High levels of serum interleukin-10 are associated with a poor response to interferon treatment in patients with chronic hepatitis C. (English)

1 reference

12 November 2017

1 reference

N Kuzushita

1

1 reference

12 November 2017

N Hayashi

2

1 reference

12 November 2017

K Katayama

3

1 reference

12 November 2017

T Kanto

4

1 reference

12 November 2017

M Oshita

5

1 reference

12 November 2017

H Hagiwara

6

1 reference

12 November 2017

A Kasahara

7

1 reference

12 November 2017

H Fusamoto

8

1 reference

12 November 2017

T Kamada

9

1 reference

12 November 2017

1 February 1997

1 reference

Scandinavian Journal of Gastroenterology

12 November 2017

1 reference

12 November 2017

32

1 reference

12 November 2017

169-174

1 reference

12 November 2017

2

1 reference

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

12 November 2017

1 reference

https://api.crossref.org/works/10.3109%2F00365529709000188

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529709000188

Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529709000188

Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529709000188

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529709000188

Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529709000188

A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529709000188

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529709000188

Biological properties of interleukin 10.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529709000188

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529709000188

Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529709000188

Interleukin 10 production correlates with pathology in human Leishmania donovani infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529709000188

Adhesion receptors of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529709000188

Detection of circulating intercellular adhesion molecule-1 in chronic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529709000188

Serum intercellular adhesion molecule-1 levels in chronic hepatitis C: association with disease activity and response to interferon alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529709000188

Selection of a human T helper type 1-like T cell subset by mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529709000188

Interferon gamma inhibits interleukin 10 production by monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529709000188

Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529709000188

Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529709000188

Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepat

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529709000188

Functional evidence that intercellular adhesion molecule-1 (icam-1) is a ligand for lfa-1d-ependent adhesion in t cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529709000188

10.3109/00365529709000188

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference